Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
GUD | Toronto | CAD | Real-time | |
GUD | CBOE Canada | CAD | Real-time |
For the three months ended 31 March 2022, Knight Therapeutics Inc revenues increased 39% to C$63.8M. Net loss totaled C$18.8M vs. income of C$3.6M. Revenues reflect Brazil segment increase of 79% to C$28.3M, Colombia segment increase of 42% to C$11.4M. Net loss reflects EFVI decrease from C$4.8M (income) to C$16.3M (expense), Amortization of intangible assets increase from C$5.3M to C$11.3M (expense).
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Revenue | 63.81 | 58.27 | 73.34 | 65.8 |
Gross Profit | 32.48 | 28.2 | 37.77 | 28.87 |
Operating Income | -0.04 | -14.43 | 4.11 | 0.2 |
Net Income | -18.81 | -8.3 | -8.59 | 29 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Total Assets | 995.42 | 991.89 | 1037.61 | 1043.65 |
Total Liabilities | 165.84 | 149.87 | 165.02 | 154.21 |
Total Equity | 829.58 | 842.02 | 872.6 | 889.44 |
Period Ending: | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
---|---|---|---|---|
Period Length: | 3 Months | 12 Months | 9 Months | 6 Months |
Cash From Operating Activities | 12.88 | 44.62 | 39.94 | 29.62 |
Cash From Investing Activities | 20.82 | -105.28 | -114.75 | -109.04 |
Cash From Financing Activities | -6.81 | -78.31 | -55.42 | -39.22 |
Net Change in Cash | 27.49 | -143.63 | -137.1 | -127.01 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review